Parlodel Indications/Uses

Adults and Pediatrics (aged 7-17 years): The safety and effectiveness of bromocriptine in pediatric patients has only been established for the Prolactinomas and Acromegaly indications, in pediatrics aged 7-17 years (see Precautions).
Prolactinomas: Conservative treatment of prolactin-secreting pituitary micro- or macro-adenomas; Prior to surgery in order to reduce tumour size and to facilitate removal; After surgery if prolactin level is still elevated.
Acromegaly: As an adjunct, or in special cases as an alternative, to surgery or radiotherapy.
Adults: Parkinson's disease: All stages of idiopathic and postencephalitic Parkinson's disease, either as monotherapy or in combination with other antiparkinsonian drugs. Hyperprolactinemia in men: Prolactin-related hypogonadism (oligospermia, loss of libido, impotence).
Menstrual cycle disorders, female infertility: Prolactin-dependent hyperprolactinemic or apparently normoprolactinemic conditions: Amenorrhea (with or without galactorrhea), oligomenorrhea; luteal phase deficiency; drug-induced hyperprolactinemic disorders (e.g. induced by certain psychotropic or antihypertensive agents).
Prolactin-independent female infertility: Polycystic ovary syndrome; anovulatory cycles (supplementary to anti-estrogens, e.g. clomiphene).
Inhibition of lactation for medical reasons: Prevention or suppression of puerperal lactation; Prevention of lactation after abortion; Incipient puerperal mastitis.
Parlodel is not recommended for the routine prevention or suppression of puerperal breast engorgement which can be adequately treated with simple analgesics and breast support.
Other: There is insufficient evidence of efficacy of Parlodel in the treatment of premenstrual symptoms and benign breast disease. The use of Parlodel in patients with these conditions is therefore not recommended.